XML 49 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Tables)
12 Months Ended
Dec. 31, 2011
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information
(In millions)
2011
 
2010
 
2009
Net sales:
 
 
 
 
 
Europe
$
848.9

 
$
796.0

 
$
768.9

Asia Pacific
714.0

 
584.0

 
494.0

Tupperware North America
352.0

 
331.5

 
296.9

Beauty North America
395.5

 
406.0

 
391.6

South America
274.6

 
182.9

 
176.1

Total net sales
$
2,585.0

 
$
2,300.4

 
$
2,127.5

Segment profit:
 
 
 
 
 
Europe
$
148.3

 
$
147.1

 
$
141.8

Asia Pacific
147.0

 
111.8

 
84.9

Tupperware North America
58.4

 
52.8

 
40.3

Beauty North America
37.9

 
58.9

 
52.2

South America (a)
48.6

 
24.4

 
12.7

Total segment profit
440.2

 
395.0

 
331.9

Unallocated expenses
(58.9
)
 
(56.8
)
 
(51.9
)
Re-engineering and impairment charges (b)
(7.9
)
 
(7.6
)
 
(8.0
)
Impairment of goodwill and intangibles (c)
(36.1
)
 
(4.3
)
 
(28.1
)
Gains on disposal of assets (d)
3.8

 
0.2

 
21.9

Interest expense, net (e)
(45.8
)
 
(26.8
)
 
(28.7
)
Income before taxes
$
295.3

 
$
299.7

 
$
237.1

(In millions)
2011
 
2010
 
2009
Depreciation and amortization:
 
 
 
 
 
Europe
$
21.3

 
$
20.3

 
$
21.9

Asia Pacific
9.2

 
10.6

 
11.3

Tupperware North America
10.4

 
8.5

 
8.1

Beauty North America
6.4

 
6.9

 
7.0

South America
2.1

 
1.2

 
1.2

Corporate
0.4

 
2.2

 
2.2

Total depreciation and amortization
$
49.8

 
$
49.7

 
$
51.7

Capital expenditures:
 
 
 
 
 
Europe
$
34.4

 
$
26.1

 
$
16.9

Asia Pacific
11.6

 
11.5

 
7.5

Tupperware North America
9.4

 
7.2

 
4.6

Beauty North America
3.9

 
3.5

 
3.4

South America
6.4

 
4.1

 
5.0

Corporate
8.2

 
3.7

 
9.0

Total capital expenditures
$
73.9

 
$
56.1

 
$
46.4

Identifiable assets:
 
 
 
 
 
Europe
$
395.9

 
$
397.8

 
$
409.2

Asia Pacific
330.6

 
349.6

 
338.3

Tupperware North America
130.4

 
165.3

 
156.4

Beauty North America
373.7

 
419.2

 
405.8

South America
105.4

 
95.1

 
83.5

Corporate
508.2

 
588.8

 
425.6

Total identifiable assets
$
1,844.2

 
$
2,015.8

 
$
1,818.8

____________________
a.
In the third and fourth quarter of 2009, the Company recorded $4.9 million and $3.5 million, respectively, in foreign currency losses associated with the cost to convert cash generated by the business in Venezuela at an exchange rate less favorable than had been used to translate the balance sheet at the time, and to translate the Venezuelan balance sheet as of the end of the 2009 fiscal year, for the first time, at the parallel exchange rate rather than the official exchange rate in that country. See Note 1 to the Consolidated Financial Statements, under the caption Foreign Currency Translation.
b.
The re-engineering and impairment charges line provides for severance and other exit costs. See Note 2 to the Consolidated Financial Statements.
c.
Reviews of the value of the intangible assets related to the acquisition of the Sara Lee Direct Selling units acquired in 2005 resulted in the conclusion that certain of the tradenames and goodwill had been impaired. This resulted in 2011 charges of $36.1 million related to Nutrimetics, and in 2009, in charges of $28.1 million related to Nutrimetics, NaturCare and Avroy Shlain. In 2010, the Company recorded an impairment of $4.3 million related to Swissgarde in connection with a decision to cease operating that unit as a separate business. See Note 6 to the Consolidated Financial Statements.
d.
Gains on disposal of assets in 2011 was from insurance proceeds of $3.0 million, net of cost, related to a flood in Australia, as well as $0.7 million related to the sale of land held for development near the Company's Orlando, Florida headquarters. In 2010, the Company recognized a $0.2 million gain on the sale of property at Nutrimetics Australia. In 2009, the Company recorded a pretax gain of $19.0 million as a result of insurance recoveries from a 2007 fire in South Carolina and pretax gains of $2.9 million from the sale of property in Australia.
e.
In 2011, the Company recorded $19.8 million in interest expense related to the impairment of interest rate swaps and the write off of deferred debt costs in conjunction with the early extinguishment of debt. See Note 7 to the Consolidated Financial Statements, under the caption Use of Proceeds.